Organization
APHP Hôpital Avicenne
2 abstracts
Abstract
Ixazomib and daratumumab without dexamethasone (I-Dara) in elderly frail patients with RRMM: Results of the multicenter phase 2 study (IFM 2018-02) of the Intergroupe Francophone du Myélome (IFM).Org: University Hospital of Nantes, France, Centre Hospitalier Universitaire de Poitiers, CHU Grenoble Alpes, Lille University Hospital, APHP Hôpital Avicenne,
Abstract
Comparing PD-L1 scores for predicting pembrolizumab efficacy in first-line treatment of unresectable cutaneous squamous cell carcinomas.Org: APHP Hôpital Avicenne, APHP Hôpital Bichat, Hopital Saint-André, Association de Cabinet de Radiologie et d'Imagerie Médicale, Polyclinique Saint-Côme, APHP Hôpital Saint-Louis,